Boston Scientifics Synergy Stent Narrowly Outperforms Biosensors Biomatrix NeoFlex In Danish Study
Boston Scientific’s Synergy Stent Narrowly Outperforms Biosensors’ Biomatrix NeoFlex In Danish Study
11:00 EDT 4 Apr 2019 |
SCRIP
Data from the 2,770-patient randomized SORT OUT VIII trial showed Boston Scientific’s Synergy everolimus-eluting stent is noninferior to Biosensor’s Biomatrix...
More From BioPortfolio on "Boston Scientific’s Synergy Stent Narrowly Outperforms Biosensors’ Biomatrix NeoFlex In Danish Study"